1 De Koning H J, Van Der Aalst C M, De Jong P A, et al. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial[J]. N Engl J Med, 2020, 382(6): 503-513.
2 Ning J, Li C, Yu P, et al. Radiomic analysis will add differential diagnostic value of benign and malignant pulmonary nodules: a hybrid imaging study based on [18F]FDG and [18F]FLT PET/CT[J]. Insights Imaging, 2023, 14(1): 197.
3 Nair A, Bartlett EC, Walsh S, et al. Variable radiological lung nodule evaluation leads to divergent management recommendations[J]. Eur Respir J, 2018, 52(6): 1801359.
4 Lucia F, Louis T, Cousin F, et al. Multicentric development and evaluation of [18F]FDG PET/CT and CT radiomic models to predict regional and/or distant recurrence in early-stage non-small cell lung cancer treated by stereotactic body radiation therapy[J]. Eur J Nucl Med Mol Imag, 2023: doi: 10.1007/s00259-023-06510-y.
5 Atsushi T, Masakazu T, Takahiro I, et al. Automated Classification of Pulmonary Nodules through a Retrospective Analysis of Conventional CT and Two-phase PET Images in Patients Undergoing Biopsy[J]. Asia Oceania journal of nuclear medicine & biology, 2019, 7(1): 29-37.
6 ³Â ÓÂ, Îâ ¿¡, ½ÊÀ´º, µÈ. 18F-FDG PET/CTÁªºÏCTÈýÎ¬ÖØ½¨Ôڷνá½ÚÁ¼¶ñÐÔ¼ø±ðÖеÄÓ¦ÓÃ[J]. ÖйúÐØÐÄѪ¹ÜÍâ¿ÆÁÙ´²ÔÓÖ¾, 2024, 31(3): 357-363.
7 Âí Äþ, ÕÔ Ãú, ÌïÈØÈØ, µÈ. ¶Ô±È»ùÓÚPET/CTµÄ²»Í¬·½·¨¶¨ÐÔÕï¶Ï¹ÂÁ¢ÐԷνá½ÚµÄЧÄÜ[J]. Öйú½éÈëÓ°ÏñÓëÖÎÁÆÑ§, 2020, 17(4): 233-237.
8 ÖÜ Æ½. ̽ÌÖ18F-FDG PET/CTÁªºÏCT±¡²ãɨÃè¶Ô¹ÂÁ¢ÐԷνá½ÚÁ¼¶ñÐÔ¼ø±ðµÄÁÙ´²Ó¦ÓüÛÖµ[D]. ÄÏ»ª´óѧ, 2021, DOI: 10.27234/d.cnki.gnhuu.2020.000296.
9 MacMahon H, Naidich DP, Goo JM, et al. Guidelines for management of incidental pulmonary nodules detected on CT images: From the fleischner society 2017[J]. Radiology, 2017, 284(1): 228-243.
10 ÕÅ ´º, Àî çù, ÂÀ·¢½ð, µÈ. CTÖ§Æø¹ÜÕ÷ÔÚ¼ø±ðÁ¼¶ñÐÔʵÐÔ¹ÂÁ¢ÐԷνá½Ú(¡Ü2 cm)ÖеļÛÖµ[J]. ½¾ü¾üÒ½´óѧѧ±¨, 2022, 44(21): 2206-2210.
11 ºÕÑîÑî, ºîÑÞÑÞ, ¹ù¿ÑÞ, µÈ. 18F-FDG PET/CTÏÔÏñÁªºÏHRCT¶Ô¹ÂÁ¢ÐԷνá½ÚµÄÓ¦ÓüÛÖµ[J]. ºÓ±±Ò½Ò©, 2021, 43(5): 701-704.
12 ÆáÇÛÁæ, ÅÓ æç, ²Ü Èñ, µÈ. ÎÞÖ¢×´·Î²¿Õæ¾ú¸ÐȾ18F-FDG-PET/CTÏÔÏñÎóÕï1Àý[J]. ´¨±±Ò½Ñ§ÔºÑ§±¨, 2022, 37(1): 122-123.
13 Ma T, Tian W, Zhang J, et al. Multiple pulmonary sclerosing pneumocytomas mimicking lung metastasis on 18F-FDG PET/CT: A rare case[J]. Asian J Surg, 2024, doi: 10.1016/j.asjsur.2024.05.153.
14 Zhan YY, Han Y, Xing Y, et al. Combined PET/CT and Autoantibody Detection in Lung Nodules Diagnosis[J]. Altern Ther Health Med, 2024, AT9525.
15 Áõ ÓÀ, ³Â Åô, ËïÕñ¹ú, µÈ.18F-FDG PET/CT²ÎÊýSUVmaxÔÚ¹ÂÁ¢ÐԷνá½ÚÕï¶ÏÖеÄÓ¦ÓÃ[J]. º£ÄÏҽѧ, 2020, 31(19): 2525-2528.
16 Weir-McCall JR, Harris3 S, Miles KA, et al. Impact of solitary pulmonary nodule size on qualitative and quantitative assessment using 18F-fluorodeoxyglucose PET/CT: the SPUTNIK trial[J]. Eur J Nucl Med Mol Imaging, 2021, 48(5): 1560-1569.
17 Marin A, Murchison JT, Skwarski KM, et al. Can dynamic imaging,using 18F-FDG PET/CT and CT perfusion differentiate between benign and malignant pulmonary nodules?[J]. Radiol Oncol, 2021, 55(3): 259-267.
18 Rafael Paez, Chirayu Shah, Angelina J Cords, et al. 18F-FSPG PET imaging for the evaluation of indeterminate pulmonary nodules[J]. PloS one, 2022, 17(3): e0265427.
19 Zhou LM, Yuan LL, Gao Y, et al. Nucleophosmin 1 overexpression correlates with 18F-FDG PET/CT metabolic parameters and improves diagnostic accuracy in patients with lung adenocarcinoma[J]. Eur J Nucl Med Mol Imag, 2021, 48(3): 904-912.
20 Äß Ã÷.[¡«(18)F]FDG PET/CTÓ°Ïñ×éѧÔÚ·ÇСϸ°û·Î°©¾«×¼Õï¶ÏºÍÔ¤ºóÆÀ¹ÀÖеÄÓ¦ÓÃ[D]. ɽ¶«´óѧ, 2023, DOI: 10.27272/d.cnki.gshdu.2023.000288.
21 Dimitris P, Saima R, Alimuddin Z, et al. Towards more accurate 18F-fluorodeoxyglucose positron emission tomography(18F-FDG PET imaging in Active and Latent Tuberculosis[J]. Int J Infect Dis, 2020, 92S: S85-S90.
22 ÕÅÀû²·, Öì ÀÚ, Öì Ïæ, µÈ. 18F-FDG PET/CT˫ʱÏàÏÔÏñ´úл²ÎÊý¶Ô¹ÂÁ¢ÐԷνá½ÚµÄÕï¶Ï¼ÛÖµ[J]. °©Ö¢, 2020, 39(12): 563-570.
23 Garcia-Velloso JM, Bastarrika G, De-Torres PJ, et al. Assessment of indeterminate pulmonary nodules detected in lung cancer screening: Diagnostic accuracy of FDG PET/CT[J]. Lung Cancer, 2016, 97: 81-86.
24 Buck AK, Halter G, Schirrmeister H, et al. Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG[J]. J Nucl Med, 2003, 44(9): 1426-1431.
25 Yavuz Sami Salihoglu, Rabiye Uslu Erdemir, Bü
ÿðþ ‰D ra Aydur Püren, et al. Diagnostic performance of machine learning models based on?18F-FDG PET/CT radiomic features in the classification of solitary pulmonary nodules[J]. Mol Imaging Radionucl Ther, 2022, 31(2): 82-88.
26 Ohno Y, Fujisawa Y, Yui M, et al. Solitary pulmonary nodule: Comparison of quantitative capability for differentiation and management among dynamic CE-perfusion MRI at 3 T system, dynamic CE-perfusion ADCT and FDG-PET/CT[J]. Eur J Radiol,2019, 115: 22-30.
27 ÀµÖÇ·å, Ñî ºé, ÂÀÕñº®. 18F-FDG PET/CT¡¢HRCTÁªºÏѪÇåÖ×Áö±êÖ¾ÎïÕï¶Ï¹ÂÁ¢ÐԷνá½ÚµÄ¼ÛÖµ·ÖÎö[J]. Öйúҽѧ´´ÐÂ, 2022, 19(11): 137-140.
28 Li Y, Shi YB, Hu CF. 18F-FDG PET/CT based model for predicting malignancy in pulmonary nodules: a meta-analysis[J]. J Cardiothorac Surg, 2024, 19(1): 148.
29 Zhao HC, Xu QS, Shi YB, et al. Clinical-radiological predictive model in differential diagnosis of small(¡Ü20 mm)solitary pulmonary nodules[J]. BMC Pulm Med, 2021, 21: 281.
30 Li L, Guo C, Wan JL, et al. The use of carcinoembryonic antigen levels to predict lung nodule malignancy: a meta-analysis[J]. Acta Clin Belg, 2022, 77: 227-232.